Share

Bosch, Jaime es

List of all publications

Publishing since 1979 (Dinosaur)

    2010

  1. Journal Article Mejias M, Garcia-Pras E, Gallego J, Mendez R, Bosch J, Fernandez M. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.  J. Hepatol.  2010;52;4  Link to Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.
  2. Journal ArticleResearch Support, N.I.H., ExtramuralReview Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis.  N. Engl. J. Med.  2010;362;9  Link to Management of varices and variceal hemorrhage in cirrhosis.
  3. Journal Article Melgosa MT, Ricci GL, García-Pagan JC, Blanco I, Escribano P, Abraldes JG, Roca J, Bosch J, Barberà JA. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.  Liver Transpl.  2010;16;3  Link to Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.

    4. 2009

  4. Journal Article Coll M, Martell M, Raurell I, Ezkurdia N, Cuenca S, Hernández-Losa J, Esteban R, Guardia J, Bosch J, Genescà J. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.  Liver Int.  2009  Link to Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
  5. Journal Article Berzigotti A, Bellot P, De Gottardi A, Garcia-Pagan JC, Gagnon C, Spénard J, Bosch J. NCX-1000, a Nitric Oxide-Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study.  Am. J. Gastroenterol.  2009  Link to NCX-1000, a Nitric Oxide-Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study.
  6. Journal Article Ullrich E, Bosch J, Aigner M, Völkl S, Dudziak D, Spriewald B, Schuler G, Andreesen R, Mackensen A. Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany.  Cancer Immunol. Immunother.  2009  Link to Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany.
  7. Journal ArticleReview Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease.  Nat Rev Gastroenterol Hepatol  2009;6;10  Link to The clinical use of HVPG measurements in chronic liver disease.
  8. CommentEditorialResearch Support, N.I.H., Extramural Bosch J, Garcia-Tsao G. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is...  Hepatology  2009;50;3  Link to Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is...
  9. Journal Article La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.  J. Hepatol.  2009;51;2  Link to Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
  10. Journal ArticleMulticenter StudyRandomized Controlled Trial García-Pagán JC, Villanueva C, Albillos A, Bañares R, Morillas R, Abraldes JG, Bosch J. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.  Gut  2009;58;8  Link to Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
  11. Journal Article Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, Garcia-Pagan JC. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.  Am. J. Gastroenterol.  2009;104;7  Link to Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
  12. Journal Article Muñoz J, Coll O, Juncosa T, Vergés M, del Pino M, Fumado V, Bosch J, Posada EJ, Hernandez S, Fisa R, Boguña JM, Gállego M, Sanz S, Portús M, Gascón J. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain.  Clin. Infect. Dis.  2009;48;12  Link to Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain.
  13. Journal ArticleResearch Support, N.I.H., Extramural Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, Ripoll C, Maurer R, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Makuch R, Rendon G. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.  Clin. Gastroenterol. Hepatol.  2009;7;6  Link to Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.
  14. Journal ArticleResearch Support, N.I.H., Extramural Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.  J. Hepatol.  2009;50;5  Link to Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
  15. Journal Article Dominguez M, Miquel R, Colmenero J, Moreno M, García-Pagán JC, Bosch J, Arroyo V, Ginès P, Caballería J, Bataller R. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.  Gastroenterology  2009;136;5  Link to Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
  16. Journal ArticleMulticenter StudyRandomized Controlled Trial Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.  Gastroenterology  2009;136;5  Link to Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
  17. Journal ArticleReview Yusuf S, Lonn E, Bosch J. Lipid lowering for primary prevention.  Lancet  2009;373;9670  Link to Lipid lowering for primary prevention.
  18. Journal Article Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.  Hepatology  2009;49;4  Link to Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
  19. Journal ArticleReview Fernández M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogenesis in liver disease.  J. Hepatol.  2009;50;3  Link to Angiogenesis in liver disease.
  20. Journal Article Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, Berzigotti A, Bosch J, Fernandez M. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.  J. Hepatol.  2009;50;2  Link to Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.
  21. Evaluation StudiesJournal Article Laviña B, Gracia-Sancho J, Rodríguez-Vilarrupla A, Chu Y, Heistad DD, Bosch J, García-Pagán JC. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.  Gut  2009;58;1  Link to Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
  22. Evaluation StudiesJournal ArticleMulticenter Study Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.  Eur. J. Clin. Invest.  2009;39;1  Link to Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
  23. CommentEditorial Bosch J. Towards the non-invasive diagnosis of cirrhosis: the nuts-cirrhosis connection.  J. Hepatol.  2009;50;1  Link to Towards the non-invasive diagnosis of cirrhosis: the nuts-cirrhosis connection.

    24. 2008

  24. Journal Article Turnes J, García-Pagán JC, González M, Aracil C, Calleja JL, Ripoll C, Abraldes JG, Bañares R, Villanueva C, Albillos A, Ayuso JR, Gilabert R, Bosch J. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation.  Clin. Gastroenterol. Hepatol.  2008;6;12  Link to Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation.
  25. CommentLetter Thalheimer U, Bosch J, Patch D, Burroughs A. Improved survival with nonselective beta blockers.  Hepatology  2008;48;6  Link to Improved survival with nonselective beta blockers.
  26. Journal ArticleMulticenter Study Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Abraldes JG, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.  Gastroenterology  2008;135;3  Link to TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.
  27. Evaluation StudiesJournal Article Arena U, Vizzutti F, Abraldes JG, Corti G, Stasi C, Moscarella S, Milani S, Lorefice E, Petrarca A, Romanelli RG, Laffi G, Bosch J, Marra F, Pinzani M. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C.  Gut  2008;57;9  Link to Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C.
  28. Journal ArticleReview Garcia-Pagán JC, Hernández-Guerra M, Bosch J. Extrahepatic portal vein thrombosis.  Semin. Liver Dis.  2008;28;3  Link to Extrahepatic portal vein thrombosis.
  29. Journal Article Matei V, Rodríguez-Vilarrupla A, Deulofeu R, García-Calderó H, Fernández M, Bosch J, Garcia-Pagán JC. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.  J. Hepatol.  2008;49;2  Link to Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
  30. Journal ArticleReview Garcia-Pagan JC, De Gottardi A, Bosch J. Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients.  Aliment. Pharmacol. Ther.  2008;28;2  Link to Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients.
  31. Journal Article Coll M, Genescà J, Raurell I, Rodríguez-Vilarrupla A, Mejías M, Otero T, Oria M, Esteban R, Guardia J, Bosch J, Martell M. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.  J. Hepatol.  2008;49;1  Link to Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
  32. Journal ArticleReview Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications.  Gastroenterology  2008;134;6  Link to Portal hypertension and its complications.
  33. Journal Article Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, García-Pagan JC. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis.  Am. J. Gastroenterol.  2008;103;5  Link to Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis.
  34. Journal ArticleReview Bellot P, García-Pagán JC, Abraldes JG, Bosch J. Primary prophylaxis of esophageal variceal bleeding in cirrhosis.  Gastroenterol. Clin. Biol.  2008;32;5 Pt 1  Link to Primary prophylaxis of esophageal variceal bleeding in cirrhosis.
  35. Congresses Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference.  Hepatology  2008;47;5  Link to Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference.
  36. Journal ArticleMulticenter StudyRandomized Controlled Trial Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, D'Amico G, Lebrec D, de Franchis R, Fabricius S, Cai Y, Bendtsen F. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.  Hepatology  2008;47;5  Link to Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
  37. Journal ArticleReview Tiani C, Abraldes JG, Bosch J. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding.  Dig Liver Dis  2008;40;5  Link to Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding.
  38. Journal ArticleRandomized Controlled Trial Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.  Diabetes Care  2008;31;5  Link to Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
  39. Journal Article Rodríguez-Vilarrupla A, Graupera M, Matei V, Bataller R, Abraldes JG, Bosch J, García-Pagán JC. Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.  Liver Int.  2008;28;4  Link to Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.
  40. Journal Article Gracia-Sancho J, Laviña B, Rodríguez-Vilarrupla A, García-Calderó H, Fernández M, Bosch J, García-Pagán JC. Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability.  Hepatology  2008;47;4  Link to Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability.
  41. Journal ArticleReview Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. Portal hypertension and gastrointestinal bleeding.  Semin. Liver Dis.  2008;28;1  Link to Portal hypertension and gastrointestinal bleeding.
  42. Journal ArticleMulticenter Study Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci A-Pagán JC, Bosch J. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.  J. Hepatol.  2008;48;2  Link to Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.
  43. Journal ArticleResearch Support, N.I.H., Extramural Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, Maurer R, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Makuch R. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis.  Hepatology  2008;47;1  Link to Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis.
  44. Journal ArticleReview Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options.  J. Hepatol.  2008;48 Suppl 1  Link to The management of portal hypertension: rational basis, available treatments and future options.
  45. Journal Article González-Navajas JM, Bellot P, Francés R, Zapater P, Muñoz C, García-Pagán JC, Pascual S, Pérez-Mateo M, Bosch J, Such J. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin.  J. Hepatol.  2008;48;1  Link to Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin.
  46. Journal Article Caro L, Sánchez C, Rodríguez P, Bosch J. Endoscopic balloon dilation of anastomotic strictures occurring after laparoscopic gastric bypass for morbid obesity.  Dig Dis  2008;26;4  Link to Endoscopic balloon dilation of anastomotic strictures occurring after laparoscopic gastric bypass for morbid obesity.
  47. Journal Article Duley L, Antman K, Arena J, Avezum A, Blumenthal M, Bosch J, Chrolavicius S, Li T, Ounpuu S, Perez AC, Sleight P, Svard R, Temple R, Tsouderous Y, Yunis C, Yusuf S. Specific barriers to the conduct of randomized trials.  Clin Trials  2008;5;1  Link to Specific barriers to the conduct of randomized trials.
  48. Journal Article Yusuf S, Bosch J, Devereaux PJ, Devereaus PJ, Collins R, Baigent C, Granger C, Califf R, Temple R. Sensible guidelines for the conduct of large randomized trials.  Clin Trials  2008;5;1  Link to Sensible guidelines for the conduct of large randomized trials.

    49. 2007

  49. Journal Article Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.  Gastroenterology  2007;133;6  Link to How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.
  50. Journal ArticleReview Abraldes JG, Bosch J. The treatment of acute variceal bleeding.  J. Clin. Gastroenterol.  2007;41 Suppl 3  Link to The treatment of acute variceal bleeding.
  51. Journal ArticleReview Bosch J. Vascular deterioration in cirrhosis: the big picture.  J. Clin. Gastroenterol.  2007;41 Suppl 3  Link to Vascular deterioration in cirrhosis: the big picture.
  52. Journal Article Fernandez M, Mejias M, Garcia-Pras E, Mendez R, Garcia-Pagan JC, Bosch J. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.  Hepatology  2007;46;4  Link to Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
  53. Journal Article Gracia-Sancho J, Laviña B, Rodríguez-Vilarrupla A, Brandes RP, Fernández M, Bosch J, García-Pagán JC. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.  Gastroenterology  2007;133;3  Link to Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
  54. Evaluation StudiesJournal ArticleRandomized Controlled TrialResearch Support, N.I.H., Extramural Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.  Gastroenterology  2007;133;2  Link to Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
  55. In VitroJournal Article Gracia-Sancho J, Laviña B, Rodríguez-Vilarrupla A, García-Calderó H, Bosch J, García-Pagán JC. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.  J. Hepatol.  2007;47;2  Link to Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.
  56. Journal Article Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.  Liver Transpl.  2007;13;8  Link to An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
  57. Journal ArticleMulticenter StudyRandomized Controlled Trial Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM, Rousseau H, Bosch J, Vinel JP. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.  Liver Int.  2007;27;6  Link to Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
  58. English AbstractJournal Article Suárez MM, Bautista RM, Almela M, Soriano A, Marco F, Bosch J, Martínez JA, Bové A, Trilla A, Mensa J. [Listeria monocytogenes bacteremia: analysis of 110 episodes]  Med Clin (Barc)  2007;129;6  Link to [Listeria monocytogenes bacteremia: analysis of 110 episodes]
  59. Journal Article Abraldes JG, Rodríguez-Vilarrupla A, Graupera M, Zafra C, García-Calderó H, García-Pagán JC, Bosch J. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.  J. Hepatol.  2007;46;6  Link to Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.
  60. Journal ArticleRandomized Controlled Trial Carrión JA, Navasa M, García-Retortillo M, García-Pagan JC, Crespo G, Bruguera M, Bosch J, Forns X. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.  Gastroenterology  2007;132;5  Link to Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.
  61. Journal ArticleResearch Support, N.I.H., Extramural Bosch J, Buscaglia CA, Krumm B, Ingason BP, Lucas R, Roach C, Cardozo T, Nussenzweig V, Hol WG. Aldolase provides an unusual binding site for thrombospondin-related anonymous protein in the invasion machinery of the malaria parasite.  Proc. Natl. Acad. Sci. U.S.A.  2007;104;17  Link to Aldolase provides an unusual binding site for thrombospondin-related anonymous protein in the invasion machinery of the malaria parasite.
  62. Journal Article Angermayr B, Fernandez M, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.  Gut  2007;56;4  Link to NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
  63. Journal ArticleReview Rodríguez-Vilarrupla A, Bosch J, García-Pagán JC. Potential role of antioxidants in the treatment of portal hypertension.  J. Hepatol.  2007;46;2  Link to Potential role of antioxidants in the treatment of portal hypertension.
  64. Journal Article Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, Jares P, Bosch J, Arroyo V, Caballería J, Ginès P. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.  Gastroenterology  2007;132;2  Link to Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.
  65. Journal ArticleMulticenter Study Albillos A, Bañares R, González M, Catalina MV, Pastor O, Gonzalez R, Ripoll C, Bosch J. The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis.  Gut  2007;56;2  Link to The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis.
  66. Journal ArticleReview Rodríguez-Vilarrupla A, Fernández M, Bosch J, García-Pagán JC. Current concepts on the pathophysiology of portal hypertension.  Ann Hepatol  2007;6;1  Link to Current concepts on the pathophysiology of portal hypertension.
  67. Journal Article March S, Graupera M, Rosa Sarrias M, Lozano F, Pizcueta P, Bosch J, Engel P. Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule.  Am. J. Pathol.  2007;170;1  Link to Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule.

    68. 2006

  68. Evaluation StudiesJournal Article Carrión JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.  Liver Transpl.  2006;12;12  Link to Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.
  69. Journal ArticleReview D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.  Gastroenterology  2006;131;5  Link to Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.
  70. Journal ArticleReview Bosch J, Garcia-Pagán JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease.  Semin. Liver Dis.  2006;26;4  Link to Measurement of portal pressure and its role in the management of chronic liver disease.
  71. Journal ArticleMulticenter StudyRandomized Controlled Trial Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR. Effect of ramipril on the incidence of diabetes.  N. Engl. J. Med.  2006;355;15  Link to Effect of ramipril on the incidence of diabetes.
  72. Journal ArticleMulticenter StudyRandomized Controlled Trial Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.  Lancet  2006;368;9541  Link to Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
  73. CommentEditorial Bosch J. Predictions from a hard liver.  J. Hepatol.  2006;45;2  Link to Predictions from a hard liver.
  74. Journal Article Luca A, Miraglia R, Caruso S, Milazzo M, Gidelli B, Bosch J. Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension.  Liver Transpl.  2006;12;8  Link to Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension.
  75. Journal Article Matei V, Rodríguez-Vilarrupla A, Deulofeu R, Colomer D, Fernández M, Bosch J, Garcia-Pagán JC. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.  Hepatology  2006;44;1  Link to The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
  76. Journal Article Andreu V, Garcia-Pagan JC, Lionetti R, Piera C, Abraldes JG, Bosch J. Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertension.  J. Hepatol.  2006;44;6  Link to Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertension.
  77. Journal Article Angermayr B, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J, Fernandez M. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats.  J. Hepatol.  2006;44;6  Link to Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats.
  78. Letter Conget I, Piquer S, Julià M, Gomis R, Esmatjes E, García-Pagán JC, Bosch J, Gilabert R, Ricart MJ, Fernández-Cruz L, Manyalich M. Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route.  Transplantation  2006;81;8  Link to Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route.
  79. Journal Article Mínguez B, García-Pagán JC, Bosch J, Turnes J, Alonso J, Rovira A, Córdoba J. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.  Hepatology  2006;43;4  Link to Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
  80. Journal ArticleResearch Support, N.I.H., Extramural Bosch J, Turley S, Daly TM, Bogh SM, Villasmil ML, Roach C, Zhou N, Morrisey JM, Vaidya AB, Bergman LW, Hol WG. Structure of the MTIP-MyoA complex, a key component of the malaria parasite invasion motor.  Proc. Natl. Acad. Sci. U.S.A.  2006;103;13  Link to Structure of the MTIP-MyoA complex, a key component of the malaria parasite invasion motor.
  81. Journal ArticleRandomized Controlled Trial Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.  Am. J. Gastroenterol.  2006;101;3  Link to Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
  82. Comparative StudyJournal Article Blasco A, Forns X, Carrión JA, García-Pagán JC, Gilabert R, Rimola A, Miquel R, Bruguera M, García-Valdecasas JC, Bosch J, Navasa M. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.  Hepatology  2006;43;3  Link to Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.
  83. Journal ArticleRandomized Controlled Trial Hernández-Guerra M, García-Pagán JC, Turnes J, Bellot P, Deulofeu R, Abraldes JG, Bosch J. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.  Hepatology  2006;43;3  Link to Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
  84. Journal Article Turnes J, Hernández-Guerra M, Abraldes JG, Bellot P, Oliva R, García-Pagán JC, Bosch J. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.  Hepatology  2006;43;1  Link to Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
  85. Journal Article Hernández-Guerra M, López E, Bellot P, Piera C, Turnes J, Abraldes JG, Bosch J, García-Pagán JC. Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome.  Hepatology  2006;43;1  Link to Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome.
  86. Journal Article Yusuf S, Bosch J. Independent design and conduct of clinical trials.  Clin Trials  2006;3;6  Link to Independent design and conduct of clinical trials.

    87. 2005

  87. Comparative StudyJournal Article Abraldes JG, Gilabert R, Turnes J, Nicolau C, Berzigotti A, Aponte J, Bru C, Bosch J, García-Pagán JC. Utility of color Doppler ultrasonography predicting tips dysfunction.  Am. J. Gastroenterol.  2005;100;12  Link to Utility of color Doppler ultrasonography predicting tips dysfunction.
  88. Journal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, N.I.H., Extramural Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.  N. Engl. J. Med.  2005;353;21  Link to Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
  89. Journal Article Martinez-Palli G, Drake BB, Garcia-Pagan JC, Barbera JA, Arguedas MR, Rodriguez-Roisin R, Bosch J, Fallon MB. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.  World J. Gastroenterol.  2005;11;43  Link to Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.
  90. Journal ArticleReview Garcia-Pagán JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension.  Nature clinical practice. Gastroenterology & hepatology  2005;2;11  Link to Endoscopic band ligation in the treatment of portal hypertension.
  91. Journal ArticleReview Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension.  Clin Liver Dis  2005;9;4  Link to The management of portal hypertension.
  92. Journal Article Ratti L, Pozzi M, Bosch J. Pathophysiology of portal hypertension in HCV-related cirrhosis. Putative role of assessment of portal pressure gradient in Peginterferon-treated patients.  Dig Liver Dis  2005;37;11  Link to Pathophysiology of portal hypertension in HCV-related cirrhosis. Putative role of assessment of portal pressure gradient in Peginterferon-treated patients.
  93. Case ReportsJournal Article Alvarez-Larrán A, Abraldes JG, Cervantes F, Hernández-Guerra M, Vizzutti F, Miquel R, Gilabert R, Giusti M, Garcia-Pagan JC, Bosch J. Portal hypertension secondary to myelofibrosis: a study of three cases.  Am. J. Gastroenterol.  2005;100;10  Link to Portal hypertension secondary to myelofibrosis: a study of three cases.
  94. Journal Article March S, Garcia-Pagán JC, Massaguer A, Pizcueta P, Panés J, Engel P, Bosch J. P-selectin mediates leukocyte rolling in concanavalin-A-induced hepatitis.  Liver Int.  2005;25;5  Link to P-selectin mediates leukocyte rolling in concanavalin-A-induced hepatitis.
  95. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, Navasa M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.  Hepatology  2005;42;3  Link to A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
  96. Journal Article Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodés J, Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.  J. Hepatol.  2005;43;1  Link to Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
  97. Journal ArticleReview Hernández-Guerra M, García-Pagán JC, Bosch J. Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension.  J. Clin. Gastroenterol.  2005;39;4 Suppl 2  Link to Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension.
  98. Journal Article Graupera M, March S, Engel P, Rodés J, Bosch J, García-Pagán JC. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.  Am. J. Physiol. Gastrointest. Liver Physiol.  2005;288;4  Link to Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.
  99. Clinical TrialJournal ArticleRandomized Controlled Trial Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.  JAMA  2005;293;11  Link to Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
  100. CommentEditorial Bosch J, Reverter JC. The coagulopathy of cirrhosis: myth or reality?  Hepatology  2005;41;3  Link to The coagulopathy of cirrhosis: myth or reality?
  101. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Bosch J. Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?  Nature clinical practice. Gastroenterology & hepatology  2005;2;1  Link to Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?
  102. Journal ArticleReview Bosch J, Abraldes JG. Variceal bleeding: pharmacological therapy.  Dig Dis  2005;23;1  Link to Variceal bleeding: pharmacological therapy.

    103. 2004

  103. Clinical TrialControlled Clinical TrialJournal Article Hernández-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, García-Pagán JC. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.  Hepatology  2004;40;5  Link to PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
  104. Clinical TrialJournal ArticleRandomized Controlled Trial Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, González Abraldes J, Fabricius S, Erhardtsen E, de Franchis R. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial.  Gastroenterology  2004;127;4  Link to Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial.
  105. Clinical TrialJournal Article Fernández J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jiménez W, Bosch J, Arroyo V. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.  J. Hepatol.  2004;41;3  Link to Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
  106. Journal ArticleReview Dell'era A, Bosch J. Review article: the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding.  Aliment. Pharmacol. Ther.  2004;20 Suppl 3  Link to Review article: the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding.
  107. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Gerstein HC, Yusuf S, Holman R, Bosch J, Pogue J. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.  Diabetologia  2004;47;9  Link to Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.
  108. Clinical TrialClinical Trial, Phase IIJournal ArticleMulticenter Study Richardson P, Schlossman R, Jagannath S, Alsina M, Desikan R, Blood E, Weller E, Mitsiades C, Hideshima T, Davies F, Doss D, Freeman A, Bosch J, Patin J, Knight R, Zeldis J, Dalton W, Anderson K. Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity.  Mayo Clin. Proc.  2004;79;7  Link to Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity.
  109. Journal ArticleReview Abraldes JG, García-Pagán JC, Bosch J. [Functional component of portal hypertension]  Gastroenterol Hepatol  2004;27;6  Link to [Functional component of portal hypertension]
  110. CommentLetter Garcia-Pagán JC, Bosch J. Monitoring of HVPG during pharmacological therapy: evidence in favor of the prognostic value of a 20% reduction.  Hepatology  2004;39;6  Link to Monitoring of HVPG during pharmacological therapy: evidence in favor of the prognostic value of a 20% reduction.
  111. BiographyClassical ArticleCommentHistorical ArticleJournal Article García-Pagán JC, Bosch J. The resistance of the cirrhotic liver: a new target for the treatment of portal hypertension. 1985.  J. Hepatol.  2004;40;6  Link to The resistance of the cirrhotic liver: a new target for the treatment of portal hypertension. 1985.
  112. Journal ArticleReview Bosch J, Dell'era A. [Vasoactive drugs for the treatment of bleeding esophageal varices]  Gastroenterol. Clin. Biol.  2004;28 Spec No 2  Link to [Vasoactive drugs for the treatment of bleeding esophageal varices]
  113. Journal Article Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.  Gastroenterology  2004;126;3  Link to Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.
  114. Clinical TrialJournal ArticleRandomized Controlled Trial Zafra C, Abraldes JG, Turnes J, Berzigotti A, Fernández M, Garca-Pagán JC, Rodés J, Bosch J. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.  Gastroenterology  2004;126;3  Link to Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.
  115. Clinical TrialJournal ArticleRandomized Controlled Trial Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, Perreault P, Péron JM, Abraldes JG, Bouchard L, Bilbao JI, Bosch J, Rousseau H, Vinel JP. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.  Gastroenterology  2004;126;2  Link to Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.
  116. Journal ArticleReview Abraldes JG, Dell'Era A, Bosch J. Medical management of variceal bleeding in patients with cirrhosis.  Can. J. Gastroenterol.  2004;18;2  Link to Medical management of variceal bleeding in patients with cirrhosis.

    117. 2003

  117. Evaluation StudiesJournal Article Bargalló X, Gilabert R, Nicolau C, García-Pagán JC, Bosch J, Brú C. Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome.  AJR Am J Roentgenol  2003;181;6  Link to Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome.
  118. Journal Article Morales J, Moitinho E, Abraldes JG, Fernández M, Bosch J. Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.  Hepatology  2003;38;6  Link to Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats.
  119. CommentEditorialReview Bosch J. Decreasing hepatic vascular tone by liver-specific NO donors: wishful thinking or a promising reality?  J. Hepatol.  2003;39;6  Link to Decreasing hepatic vascular tone by liver-specific NO donors: wishful thinking or a promising reality?
  120. In VitroJournal Article Tonda R, Galán AM, Pino M, Cirera I, Bosch J, Hernández MR, Ordinas A, Escolar G. Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model.  J. Hepatol.  2003;39;6  Link to Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model.
  121. Journal Article Graupera M, García-Pagán JC, Parés M, Abraldes JG, Roselló J, Bosch J, Rodés J. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers.  J. Hepatol.  2003;39;4  Link to Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers.
  122. In VitroJournal Article Inserte J, Perelló A, Agulló L, Ruiz-Meana M, Schlüter KD, Escalona N, Graupera M, Bosch J, Garcia-Dorado D. Left ventricular hypertrophy in rats with biliary cirrhosis.  Hepatology  2003;38;3  Link to Left ventricular hypertrophy in rats with biliary cirrhosis.
  123. CommentLetter Bosch J, Hakim RM, Lazarus JM, McAllister CJ. Quality of care in profit vs not-for-profit dialysis centers.  JAMA  2003;289;23  Link to Quality of care in profit vs not-for-profit dialysis centers.
  124. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial García-Pagán JC, Morillas R, Bañares R, Albillos A, Villanueva C, Vila C, Genescà J, Jimenez M, Rodriguez M, Calleja JL, Balanzó J, García-Durán F, Planas R, Bosch J. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.  Hepatology  2003;37;6  Link to Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
  125. Journal Article Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodés J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.  Hepatology  2003;37;4  Link to Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
  126. Clinical TrialJournal ArticleRandomized Controlled TrialReview Bosch J, García-Pagán JC. Prevention of variceal rebleeding.  Lancet  2003;361;9361  Link to Prevention of variceal rebleeding.
  127. Clinical TrialJournal ArticleRandomized Controlled Trial Bellis L, Berzigotti A, Abraldes JG, Moitinho E, García-Pagán JC, Bosch J, Rodés J. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.  Hepatology  2003;37;2  Link to Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
  128. CommentLetter Yusuf S, Bosch J, Sleight P. Preventing stroke with ramipril--authors' reply.  BMJ  2003;326;7379  Link to Preventing stroke with ramipril--authors' reply.
  129. Journal Article Graupera M, García-Pagán JC, Abraldes JG, Peralta C, Bragulat M, Corominola H, Bosch J, Rodés J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.  Hepatology  2003;37;1  Link to Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
  130. Journal Article Bellis L, Moitinho E, Abraldes JG, Graupera M, García-Pagán JC, Rodés J, Bosch J. Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt.  Gut  2003;52;1  Link to Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt.
  131. Journal ArticleResearch Support, U.S. Gov't, P.H.S.Review Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension.  J. Hepatol.  2003;38 Suppl 1  Link to Current management of portal hypertension.

    132. 2002

  132. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Bañares R, Moitinho E, Matilla A, García-Pagán JC, Lampreave JL, Piera C, Abraldes JG, De Diego A, Albillos A, Bosch J. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.  Hepatology  2002;36;6  Link to Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
  133. Clinical TrialComparative StudyJournal ArticleRandomized Controlled TrialResearch Support, U.S. Gov't, P.H.S. Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, Planas R, Bosch J, Arroyo V, Rodés J. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.  Gastroenterology  2002;123;6  Link to Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
  134. Journal ArticleReview Abraldes JG, Bosch J. Novel approaches to treat portal hypertension.  J. Gastroenterol. Hepatol.  2002;17 Suppl 3  Link to Novel approaches to treat portal hypertension.
  135. CommentEditorialReview Bosch J. A la carte or menu fixe: Improving pharmacologic therapy of portal hypertension.  Hepatology  2002;36;6  Link to A la carte or menu fixe: Improving pharmacologic therapy of portal hypertension.
  136. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.  Diabetes Care  2002;25;11  Link to Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
  137. Journal Article Escorsell A, Ginès A, Llach J, García-Pagán JC, Bordas JM, Bosch J, Rodés J. Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices.  Hepatology  2002;36;4 Pt 1  Link to Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices.
  138. Journal ArticleReview Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension.  Hepatology  2002;35;6  Link to Somatostatin and analogues in portal hypertension.
  139. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, Davies R, Ostergren J, Probstfield J. Use of ramipril in preventing stroke: double blind randomised trial.  BMJ  2002;324;7339  Link to Use of ramipril in preventing stroke: double blind randomised trial.
  140. Journal ArticleReview Burroughs AK, Groszmann R, Bosch J, Grace N, Garcia-Tsao G, Patch D, Garcia-Pagan JC, Dagher L. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?  Gut  2002;50;3  Link to Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
  141. Clinical TrialControlled Clinical TrialJournal Article Andreu V, Perello A, Moitinho E, Escorsell A, García-Pagán JC, Bosch J, Rodés J. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.  J. Hepatol.  2002;36;3  Link to Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.
  142. Journal Article Graupera M, García-Pagán JC, Titos E, Claria J, Massaguer A, Bosch J, Rodés J. 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes.  Gastroenterology  2002;122;2  Link to 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes.
  143. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Escorsell A, Bañares R, García-Pagán JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.  Hepatology  2002;35;2  Link to TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.
  144. Journal Article Perelló A, García-Pagán JC, Gilabert R, Suárez Y, Moitinho E, Cervantes F, Reverter JC, Escorsell A, Bosch J, Rodés J. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.  Hepatology  2002;35;1  Link to TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.

    145. 2001

  145. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Moitinho E, Planas R, Bañares R, Albillos A, Ruiz-del-Arbol L, Gálvez C, Bosch J. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding.  J. Hepatol.  2001;35;6  Link to Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding.
  146. Clinical TrialJournal ArticleRandomized Controlled TrialResearch Support, U.S. Gov't, P.H.S. Abraczinskas DR, Ookubo R, Grace ND, Groszmann RJ, Bosch J, Garcia-Tsao G, Richardson CR, Matloff DS, Rodés J, Conn HO. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?  Hepatology  2001;34;6  Link to Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?
  147. Case ReportsComparative StudyJournal ArticleReview Espinosa G, Font J, García-Pagan JC, Tàssies D, Reverter JC, Gaig C, Cervantes F, Cervera R, Bosch J, Ingelmo M. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.  Medicine (Baltimore)  2001;80;6  Link to Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.
  148. CommentEditorial Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving?  J. Hepatol.  2001;35;5  Link to Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving?
  149. Clinical TrialJournal ArticleRandomized Controlled Trial Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B. Ramipril and the development of diabetes.  JAMA  2001;286;15  Link to Ramipril and the development of diabetes.
  150. Journal ArticleReview González-Abraldes J, Bosch J, García-Pagán JC. Pharmacological treatment of portal hypertension.  Curr Opin Investig Drugs  2001;2;10  Link to Pharmacological treatment of portal hypertension.
  151. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial García-Pagán JC, Villanueva C, Vila MC, Albillos A, Genescà J, Ruiz-Del-Arbol L, Planas R, Rodriguez M, Calleja JL, González A, Solà R, Balanzó J, Bosch J. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.  Gastroenterology  2001;121;4  Link to Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.
  152. Journal Article Cárdenas A, Ginès P, Uriz J, Bessa X, Salmerón JM, Mas A, Ortega R, Calahorra B, De Las Heras D, Bosch J, Arroyo V, Rodés J. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis.  Hepatology  2001;34;4 Pt 1  Link to Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis.
  153. Journal Article Martin M, Romero X, de la Fuente MA, Tovar V, Zapater N, Esplugues E, Pizcueta P, Bosch J, Engel P. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1.  J. Immunol.  2001;167;7  Link to CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1.
  154. Comparative StudyJournal Article Ramírez MC, Martínez-Cuesta MA, D'Ocon P, Noguera MA, García-Zaragoza E, Bosch J, Melin P, Esplugues JV. Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats.  Naunyn Schmiedebergs Arch. Pharmacol.  2001;364;3  Link to Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats.
  155. Journal ArticleReview Escorsell A, Garcia-Pagán JC, Bosch J. Assessment of portal hypertension in humans.  Clin Liver Dis  2001;5;3  Link to Assessment of portal hypertension in humans.
  156. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial González-Abraldes J, Albillos A, Bañares R, Del Arbol LR, Moitinho E, Rodríguez C, González M, Escorsell A, García-Pagán JC, Bosch J. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.  Gastroenterology  2001;121;2  Link to Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.
  157. Case ReportsJournal Article Turnes J, García-Pagán JC, González-Abraldes J, Real M, Moitinho E, Gilabert R, Escorsell A, Muntanya X, Ginès P, Bosch J, Rodés J. Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients.  Liver Transpl.  2001;7;7  Link to Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients.
  158. Comparative StudyJournal Article de la Fuente MA, Tovar V, Villamor N, Zapater N, Pizcueta P, Campo E, Bosch J, Engel P. Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9.  Blood  2001;97;11  Link to Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9.
  159. Journal Article Pérez-Del-Pulgar S, Pizcueta P, Engel P, Bosch J, Rodés J. Neutrophil adhesion is impaired in the mesentery but not in the liver sinusoids of portal hypertensive rats.  Am. J. Physiol. Gastrointest. Liver Physiol.  2001;280;6  Link to Neutrophil adhesion is impaired in the mesentery but not in the liver sinusoids of portal hypertensive rats.
  160. Clinical TrialControlled Clinical TrialJournal ArticleMulticenter Study Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.  Ann. Intern. Med.  2001;134;8  Link to Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.
  161. Journal Article Castañeda B, Morales J, Lionetti R, Moitinho E, Andreu V, Pérez-Del-Pulgar S, Pizcueta P, Rodés J, Bosch J. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats.  Hepatology  2001;33;4  Link to Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats.
  162. Case ReportsLetter González-Abraldes J, Moitinho E, García-Pagán JC, Escorsell A, Salmerón JM, Gilabert R, Real M, Muntanyá X, Bosch J. Selective arterial embolization for life threatening hemobilia after transjugular intrahepatic portosystemic shunt placement.  J. Hepatol.  2001;34;1  Link to Selective arterial embolization for life threatening hemobilia after transjugular intrahepatic portosystemic shunt placement.
  163. Clinical TrialControlled Clinical TrialJournal Article Escorsell A, Bandi JC, Andreu V, Moitinho E, García-Pagán JC, Bosch J, Rodés J. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.  Gastroenterology  2001;120;1  Link to Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.

    164. 2000

  164. Journal ArticleReview García-Pagán JC, Perelló A, Bosch J. [Budd-Chiari syndrome]  Gastroenterol Hepatol  2000;23;10  Link to [Budd-Chiari syndrome]
  165. Journal ArticleReview García-Pagán JC, Bosch J. Medical treatment of portal hypertension.  Baillieres Best Pract Res Clin Gastroenterol  2000;14;6  Link to Medical treatment of portal hypertension.
  166. CommentEditorialReview Bosch J. Prevention of variceal rebleeding: endoscopes, drugs, and more.  Hepatology  2000;32;3  Link to Prevention of variceal rebleeding: endoscopes, drugs, and more.
  167. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Bañares R, Calès P, Pateron D, Bernard B, Vinel JP, Bosch J. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.  Hepatology  2000;32;3  Link to Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.
  168. Journal Article Debernardi-Venon W, Bandi JC, García-Pagán JC, Moitinho E, Andreu V, Real M, Escorsell A, Montanyá X, Bosch J. CO(2) wedged hepatic venography in the evaluation of portal hypertension.  Gut  2000;46;6  Link to CO(2) wedged hepatic venography in the evaluation of portal hypertension.
  169. Journal Article Bataller R, Ginès P, Nicolás JM, Görbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodés J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells.  Gastroenterology  2000;118;6  Link to Angiotensin II induces contraction and proliferation of human hepatic stellate cells.
  170. Journal Article Escorsell A, Bordas JM, Castañeda B, Llach J, García-Pagán JC, Rodés J, Bosch J. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.  Hepatology  2000;31;5  Link to Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
  171. Journal Article Cirera I, Navasa M, Rimola A, García-Pagán JC, Grande L, Garcia-Valdecasas JC, Fuster J, Bosch J, Rodes J. Ascites after liver transplantation.  Liver Transpl.  2000;6;2  Link to Ascites after liver transplantation.
  172. Comparative StudyLecturesReview Bosch J. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.  P R Health Sci J  2000;19;1  Link to The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
  173. Journal Article Castañeda B, Debernardi-Venon W, Bandi JC, Andreu V, Pérez-del-Pulgar S, Moitinho E, Pizcueta P, Bosch J. The role of portal pressure in the severity of bleeding in portal hypertensive rats.  Hepatology  2000;31;3  Link to The role of portal pressure in the severity of bleeding in portal hypertensive rats.
  174. Case ReportsClinical ConferenceJournal Article Bosch J, Pagés M, Cid MC. [A 66-year-old man with fever of 5 months evolution]  Med Clin (Barc)  2000;114;3  Link to [A 66-year-old man with fever of 5 months evolution]
  175. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.  N. Engl. J. Med.  2000;342;3  Link to Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
  176. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.  N. Engl. J. Med.  2000;342;3  Link to Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
  177. Journal ArticleReview Bosch J, García-Pagán JC. Complications of cirrhosis. I. Portal hypertension.  J. Hepatol.  2000;32;1 Suppl  Link to Complications of cirrhosis. I. Portal hypertension.
  178. Journal Article Pérez del Pulgar S, Pizcueta P, Engel P, Bosch J. Enhanced monocyte activation and hepatotoxicity in response to endotoxin in portal hypertension.  J. Hepatol.  2000;32;1  Link to Enhanced monocyte activation and hepatotoxicity in response to endotoxin in portal hypertension.

    179. 1999

  179. Journal Article Perelló A, Escorsell A, Bru C, Gilabert R, Moitinho E, García-Pagán JC, Bosch J. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.  Hepatology  1999;30;6  Link to Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.
  180. Comparative StudyJournal Article Luca A, García-Pagán JC, de Lacy AM, Escorsell A, Feu F, Visa J, Bosch J, Rodés J. Effects of end-to-side portacaval shunt and distal splenorenal shunt on systemic and pulmonary haemodynamics in patients with cirrhosis.  J. Gastroenterol. Hepatol.  1999;14;11  Link to Effects of end-to-side portacaval shunt and distal splenorenal shunt on systemic and pulmonary haemodynamics in patients with cirrhosis.
  181. Journal Article Bandi JC, Fernández M, Bernadich C, De Lacy AM, García-Pagán JC, Bosch J, Rodés J. Hyperkinetic circulation and decreased sensitivity to vasoconstrictors following portacaval shunt in the rat. Effects of chronic nitric oxide inhibition.  J. Hepatol.  1999;31;4  Link to Hyperkinetic circulation and decreased sensitivity to vasoconstrictors following portacaval shunt in the rat. Effects of chronic nitric oxide inhibition.
  182. Journal Article Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J. Prognostic value of early measurements of portal pressure in acute variceal bleeding.  Gastroenterology  1999;117;3  Link to Prognostic value of early measurements of portal pressure in acute variceal bleeding.
  183. Journal Article Kolkowski EC, Reth P, Pelusa F, Bosch J, Pujol-Borrell R, Coll J, Jaraquemada D. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.  J. Autoimmun.  1999;13;1  Link to Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.
  184. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Panés J, Pérez-del-Pulgar S, Casadevall M, Salas A, Pizcueta P, Bosch J, Anderson DC, Granger DN, Piqué JM. Impaired mesenteric leukocyte recruitment in experimental portal hypertension in the rat.  Hepatology  1999;30;2  Link to Impaired mesenteric leukocyte recruitment in experimental portal hypertension in the rat.
  185. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.  Hepatology  1999;30;1  Link to Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
  186. Journal ArticleReview García-Pagán JC, Escorsell A, Moitinho E, Bosch J. Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension.  Semin. Liver Dis.  1999;19;4  Link to Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension.
  187. Journal ArticleReview D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach.  Semin. Liver Dis.  1999;19;4  Link to Pharmacological treatment of portal hypertension: an evidence-based approach.

    188. 1998

  188. Clinical TrialJournal ArticleRandomized Controlled Trial Elizalde JI, Moitinho E, García-Pagán JC, Cirera I, Escorsell A, Bandi JC, Jiménez W, Bosch J, Piqué JM, Rodés J. Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients.  J. Hepatol.  1998;29;5  Link to Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients.
  189. Journal ArticleReview Escorsell A, Bosch J. [Terlipressin in the treatment of portal hypertension]  Gastroenterol Hepatol  1998;21;9  Link to [Terlipressin in the treatment of portal hypertension]
  190. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Escorsell A, Bordas JM, del Arbol LR, Jaramillo JL, Planas R, Bañares R, Albillos A, Bosch J. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.  J. Hepatol.  1998;29;5  Link to Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.
  191. Journal Article Sánchez M, Bruguera M, Bosch J, Rodés J, Ballesta F, Oliva R. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls.  J. Hepatol.  1998;29;5  Link to Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls.
  192. Congresses Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson JM, de Franchis R, Wagner JL, Conn HO, Rodes J. Portal hypertension and variceal bleeding: an AASLD single topic symposium.  Hepatology  1998;28;3  Link to Portal hypertension and variceal bleeding: an AASLD single topic symposium.
  193. Clinical TrialJournal ArticleRandomized Controlled Trial Bandi JC, García-Pagán JC, Escorsell A, François E, Moitinho E, Rodés J, Bosch J. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.  Hepatology  1998;28;3  Link to Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
  194. Comparative StudyJournal Article Sala-Blanch X, Fontanals J, Martínez-Palli G, Taurá P, Delgado S, Bosch J, Lacy AM, Visa J. Effects of carbon dioxide vs helium pneumoperitoneum on hepatic blood flow.  Surg Endosc  1998;12;9  Link to Effects of carbon dioxide vs helium pneumoperitoneum on hepatic blood flow.
  195. Journal Article Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jiménez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodés J. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.  Hepatology  1998;28;2  Link to Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
  196. Journal ArticleReview Bosch J. Medical treatment of portal hypertension.  Digestion  1998;59;5  Link to Medical treatment of portal hypertension.
  197. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Albillos A, García-Pagán JC, Iborra J, Bandi JC, Cacho G, Pérez-Paramo M, Escorsell A, Calleja JL, Escartín P, Bosch J. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.  Gastroenterology  1998;115;1  Link to Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
  198. Journal ArticleReview Escorsell A, Bosch J. Pathogenesis of bleeding in portal hypertension.  Digestion  1998;59 Suppl 2  Link to Pathogenesis of bleeding in portal hypertension.
  199. Journal Article Casado M, Bosch J, García-Pagán JC, Bru C, Bañares R, Bandi JC, Escorsell A, Rodríguez-Láiz JM, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rodés J. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.  Gastroenterology  1998;114;6  Link to Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.
  200. Journal Article Guevara M, Ginès P, Jiménez W, Sort P, Fernández-Esparrach G, Escorsell A, Bataller R, Bosch J, Arroyo V, Rivera F, Rodés J. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems.  Gastroenterology  1998;114;2  Link to Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems.
  201. Case ReportsJournal Article Bataller R, Sans M, Escorsell A, Elizalde JI, Bosch J, Rodés J. Esophageal variceal bleeding caused by hypoplasia of the portal vein in a patient with the Klippel-Trenaunay syndrome.  Am. J. Gastroenterol.  1998;93;2  Link to Esophageal variceal bleeding caused by hypoplasia of the portal vein in a patient with the Klippel-Trenaunay syndrome.
  202. Comparative StudyJournal Article Bernadich C, Bandi JC, Melin P, Bosch J. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.  Hepatology  1998;27;2  Link to Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
  203. Journal Article Bosch J, Brossmer R, Kemmner W, Schlag P. Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens.  Cancer Detect. Prev.  1998;22;4  Link to Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens.
  204. Journal ArticleReview Bosch J, Lebrec D, Jenkins SA. Development of analogues: successes and failures.  Scand. J. Gastroenterol. Suppl.  1998;226  Link to Development of analogues: successes and failures.
  205. Journal Article Diaz Diego EM, Nacher M, Rapado A, Serrano S, Bosch J, Aubia J, de la Piedra C. Immunoreactive osteocalcin forms in conditioned media from human osteoblast culture and in sera from healthy adult control subjects and patients with bone pathologies.  Eur. J. Clin. Invest.  1998;28;1  Link to Immunoreactive osteocalcin forms in conditioned media from human osteoblast culture and in sera from healthy adult control subjects and patients with bone pathologies.

    206. 1997

  206. Clinical TrialJournal ArticleRandomized Controlled Trial Escorsell A, Bordas JM, Feu F, García-Pagán JC, Ginès A, Bosch J, Rodés J. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.  Gastroenterology  1997;113;5  Link to Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
  207. Journal Article de la Fuente MA, Pizcueta P, Nadal M, Bosch J, Engel P. CD84 leukocyte antigen is a new member of the Ig superfamily.  Blood  1997;90;6  Link to CD84 leukocyte antigen is a new member of the Ig superfamily.
  208. Journal Article Cirera I, Elizalde JI, Piqué JM, Feu F, Casadevall M, Goldin E, Terés J, Bosch J, Rodés J. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.  Dig. Dis. Sci.  1997;42;8  Link to Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.
  209. Journal Article Bernadich C, Bandi JC, Piera C, Bosch J, Rodes J. Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: role of nitric oxide.  Hepatology  1997;26;2  Link to Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: role of nitric oxide.
  210. Journal ArticleReview García-Pagán JC, Bosch J. Pharmacological prevention of variceal bleeding. New developments.  Baillieres Clin. Gastroenterol.  1997;11;2  Link to Pharmacological prevention of variceal bleeding. New developments.
  211. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Escorsell A, Ferayorni L, Bosch J, García-Pagán JC, García-Tsao G, Grace ND, Rodés J, Groszmann RJ. The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices.  Gastroenterology  1997;112;6  Link to The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices.
  212. Clinical TrialJournal ArticleRandomized Controlled Trial Luca A, García-Pagán JC, Bosch J, Feu F, Caballería J, Groszmann RJ, Rodés J. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis.  Gastroenterology  1997;112;4  Link to Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis.
  213. Journal Article Mendez A, Fernandez M, Barrios Y, Lopez-Coviella I, Gonzalez-Mora JL, Del Rivero M, Salido E, Bosch J, Quintero E. Constitutive NOS isoforms account for gastric mucosal NO overproduction in uremic rats.  Am. J. Physiol.  1997;272;4 Pt 1  Link to Constitutive NOS isoforms account for gastric mucosal NO overproduction in uremic rats.
  214. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Escorsell A, Bandi JC, Moitinho E, Feu F, García-Pagan JC, Bosch J, Rodés J. Time profile of the haemodynamic effects of terlipressin in portal hypertension.  J. Hepatol.  1997;26;3  Link to Time profile of the haemodynamic effects of terlipressin in portal hypertension.
  215. Comparative StudyEnglish AbstractJournal Article François E, García-Pagán JC, Bru C, Feu F, Gilabert R, Escorsell A, Bosch J, Rodés J. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension]  Gastroenterol Hepatol  1997;20;1  Link to [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension]
  216. Letter Andreu A, Barranco M, Bosch J, Dopico E, Guardia C, Juncosa T, Lite J, Matas L, Sanchez F, Sanfeliu I, Sierra M, Viñas L. Prevention of perinatal group B streptococcal disease in Europe. (Group of Microbiologists for the Study and Prevention of Perinatal Group B Streptococcal Disease, in the Area of Barcelona)  Scand. J. Infect. Dis.  1997;29;5  Link to Prevention of perinatal group B streptococcal disease in Europe. (Group of Microbiologists for the Study and Prevention of Perinatal Group B Streptococcal Disease, in the Area of Barcelona)

    217. 1996

  217. English AbstractJournal Article Cobo F, Cervantes F, García-Pagán JC, Bosch J, Rozman C, Montserrat E. [Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases]  Med Clin (Barc)  1996;107;17  Link to [Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases]
  218. Journal Article García-Pagàn JC, Santos C, Barberá JA, Luca A, Roca J, Rodriguez-Roisin R, Bosch J, Rodés J. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension.  Gastroenterology  1996;111;5  Link to Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension.
  219. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.  Diabetes Care  1996;19;11  Link to Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.
  220. Journal Article Ordinas A, Escolar G, Cirera I, Viñas M, Cobo F, Bosch J, Terés J, Rodés J. Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions.  Hepatology  1996;24;5  Link to Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions.
  221. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Feu F, Ruiz del Arbol L, Bañares R, Planas R, Bosch J. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group.  Gastroenterology  1996;111;5  Link to Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group.
  222. English AbstractJournal Article Trejo R, Alvarez W, García-Pagán JC, Feu F, Escorsell A, Bruguera M, Bosch J, Rodés J. [The applicability and diagnostic effectiveness of transjugular liver biopsy]  Med Clin (Barc)  1996;107;14  Link to [The applicability and diagnostic effectiveness of transjugular liver biopsy]
  223. Journal Article Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodés J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.  Gastroenterology  1996;111;4  Link to Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.
  224. In VitroJournal Article Moreno L, Martínez-Cuesta MA, Piqué JM, Bosch J, Esplugues JV. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats.  Naunyn Schmiedebergs Arch. Pharmacol.  1996;354;4  Link to Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats.
  225. In VitroJournal Article Martínez-Cuesta MA, Moreno L, Piqué JM, Bosch J, Rodrigo J, Esplugues JV. Nitric oxide-mediated beta 2-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive rats.  Gastroenterology  1996;111;3  Link to Nitric oxide-mediated beta 2-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive rats.
  226. Journal Article Bernadich C, Fernández M, Bandi JC, Bosch J, Rodés J. Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension.  J. Hepatol.  1996;25;1  Link to Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension.
  227. Journal Article Fernández M, García-Pagán JC, Casadevall M, Mourelle MI, Piqué JM, Bosch J, Rodés J. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis.  Gastroenterology  1996;110;5  Link to Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis.
  228. Case ReportsJournal Article Sans M, Llach J, Bordas JM, Andreu V, Reverter JC, Bosch J, Mondelo F, Salmerón JM, Mas A, Terés J, Rodés J. Thrombin and ethanolamine injection therapy in arresting uncontrolled bleeding from duodenal varices.  Endoscopy  1996;28;4  Link to Thrombin and ethanolamine injection therapy in arresting uncontrolled bleeding from duodenal varices.
  229. Clinical TrialJournal ArticleRandomized Controlled Trial García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.  J. Hepatol.  1996;24;4  Link to Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
  230. Clinical TrialControlled Clinical TrialJournal ArticleRandomized Controlled Trial Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.  J. Hepatol.  1996;24;4  Link to Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
  231. Journal Article Casadevall M, Piqué JM, Cirera I, Goldin E, Elizalde I, Panés J, Martínez-Cuesta MA, Bosch J, Terés J, Rodés J. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.  Gastroenterology  1996;110;4  Link to Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.
  232. Comparative StudyJournal ArticleReview Feu F, Bosch J. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases]  Gastroenterol Hepatol  1996;19;2  Link to [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases]
  233. Clinical TrialJournal ArticleRandomized Controlled Trial Nevens F, Sprengers D, Feu F, Bosch J, Fevery J. Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions.  J. Hepatol.  1996;24;1  Link to Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions.

    234. 1995

  234. CommentLetter Carreras E, García-Pagán JC, Bosch J, Rozman C. Transvenous liver biopsies in marrow transplant recipients.  Transplantation  1995;60;11  Link to Transvenous liver biopsies in marrow transplant recipients.
  235. Comparative StudyJournal Article Cirera I, Panés J, Bordas JM, Llach J, Bosch J, Piqué JM, Terés J, Rodés J. Anemia increases gastric blood flow in noncirrhotic and cirrhotic patients.  Gastrointest. Endosc.  1995;42;5  Link to Anemia increases gastric blood flow in noncirrhotic and cirrhotic patients.
  236. Clinical TrialJournal Article Feu F, García-Pagán JC, Bosch J, Luca A, Terés J, Escorsell A, Rodés J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.  Lancet  1995;346;8982  Link to Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.
  237. Case ReportsJournal Article Sort P, Elizalde I, Llach I, Feu F, Garcia-Pagan JC, Salmeron JM, Mas A, Bosch J, Bordas JM, Rodes J. Duodenal variceal bleeding treated with a transjugular intrahepatic portosystemic shunt.  Endoscopy  1995;27;8  Link to Duodenal variceal bleeding treated with a transjugular intrahepatic portosystemic shunt.
  238. Clinical TrialJournal ArticleRandomized Controlled Trial Albillos A, Lledó JL, Rossi I, Pérez-Páramo M, Tabuenca MJ, Bañares R, Iborra J, Garrido A, Escartín P, Bosch J. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.  Gastroenterology  1995;109;4  Link to Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
  239. Clinical TrialJournal ArticleRandomized Controlled Trial Luca A, García-Pagán JC, Bosch J, Feu F, Jiménez W, Ginés A, Fernández M, Escorsell A, Arroyo V, Rodés J. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.  Hepatology  1995;22;3  Link to Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.
  240. Clinical TrialJournal ArticleRandomized Controlled Trial Cirera I, Feu F, Luca A, García-Pagán JC, Fernández M, Escorsell A, Bosch J, Rodés J. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.  Hepatology  1995;22;1  Link to Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
  241. Journal ArticleReview García-Pagán JC, Bosch J, Rodés J. The role of vasoactive mediators in portal hypertension.  Semin. Gastrointest. Dis.  1995;6;3  Link to The role of vasoactive mediators in portal hypertension.
  242. Journal ArticleMeta-Analysis D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review.  Hepatology  1995;22;1  Link to The treatment of portal hypertension: a meta-analytic review.
  243. Journal Article Fernández M, García-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJ, Piqué JM, Bosch J, Rodés J. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.  Gastroenterology  1995;108;5  Link to Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
  244. Journal Article Lacy AM, Balaguer C, Andrade E, García-Valdecasas JC, Grande L, Fuster J, Bosch J, Visa J. Laparoscopic cholecystectomy in cirrhotic patients. Indication or contradiction?  Surg Endosc  1995;9;4  Link to Laparoscopic cholecystectomy in cirrhotic patients. Indication or contradiction?
  245. Clinical TrialControlled Clinical TrialJournal ArticleRandomized Controlled Trial Luca A, García-Pagán JC, Feu F, Lopez-Talavera JC, Fernández M, Bru C, Bosch J, Rodés J. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.  Hepatology  1995;21;1  Link to Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.

    246. 1994

  246. Journal ArticleReview Bosch J, Bruix J, Mas A, Navasa M, Rodés J. Rolling review: the treatment of major complications of cirrhosis.  Aliment. Pharmacol. Ther.  1994;8;6  Link to Rolling review: the treatment of major complications of cirrhosis.
  247. Clinical TrialControlled Clinical TrialJournal Article Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.  Hepatology  1994;20;6  Link to Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
  248. Journal Article García-Pagán JC, Fernández M, Bernadich C, Pizcueta P, Piqué JM, Bosch J, Rodés J. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.  Am. J. Physiol.  1994;267;6 Pt 1  Link to Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.
  249. Journal Article Fernández M, Casadevall M, Schuligoi R, Pizcueta P, Panés J, Barrachina MD, Donnerer J, Piqué JM, Esplugues JV, Bosch J. Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats.  Hepatology  1994;20;6  Link to Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats.
  250. Journal Article Panés J, Casadevall M, Fernández M, Piqué JM, Bosch J, Casamitjana R, Cirera I, Bombí JA, Terés J, Rodés J. Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment.  Hepatology  1994;20;5  Link to Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment.
  251. Consensus Development ConferenceJournal ArticleReview Spina GP, Arcidiacono R, Bosch J, Pagliaro L, Burroughs AK, Santambrogio R, Rossi A. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992.  J. Hepatol.  1994;21;3  Link to Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992.
  252. Clinical TrialControlled Clinical TrialJournal Article Albillos A, Lledó JL, Bañares R, Rossi I, Iborra J, Calleja JL, Garrido A, Escartin P, Bosch J. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.  Hepatology  1994;20;3  Link to Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
  253. Clinical TrialControlled Clinical TrialJournal ArticleRandomized Controlled Trial Panés J, Piqué JM, Bordas JM, Casadevall M, Terés J, Bosch J, Rodés J. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy.  Hepatology  1994;20;2  Link to Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy.
  254. Journal Article Luca A, Feu F, García-Pagán JC, Jiménez W, Arroyo V, Bosch J, Rodés J. Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites.  Hepatology  1994;20;1 Pt 1  Link to Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites.
  255. Clinical TrialJournal ArticleRandomized Controlled Trial García-Pagán JC, Feu F, Luca A, Fernández M, Pizcueta P, Bosch J, Rodés J. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.  J. Hepatol.  1994;20;6  Link to Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.
  256. Journal Article García-Pagán JC, Salmerón JM, Feu F, Luca A, Ginés P, Pizcueta P, Claria J, Piera C, Arroyo V, Bosch J. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.  Hepatology  1994;19;5  Link to Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.
  257. In VitroJournal Article Gomis R, Fernández-Alvarez J, Pizcueta P, Fernández M, Casamitjana R, Bosch J, Rodés J. Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation.  Hepatology  1994;19;5  Link to Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation.
  258. Journal Article Bosch J, Bañares R, Bilbao JI, Cabrera J, Jaramillo JL, Maynar M, Planas R, Ruiz del Arbol L, del Río A, Guerra L. [Intrahepatic percutaneous portasystemic shunt]  Rev Gastroenterol Mex  1994;59;2 Suppl  Link to [Intrahepatic percutaneous portasystemic shunt]
  259. Journal Article García-Pagán JC, Feu F, Castells A, Luca A, Hermida RC, Rivera F, Bosch J, Rodés J. Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis.  Hepatology  1994;19;3  Link to Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis.
  260. Clinical TrialComparative StudyControlled Clinical TrialJournal ArticleRandomized Controlled Trial Panés J, Piqué JM, Bordas JM, Llach J, Bosch J, Terés J, Rodés J. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy.  Hepatology  1994;19;1  Link to Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy.
  261. CommentJournal Article Bosch J. Shunt surgery and beta-blockers.  J. Hepatol.  1994;20;1  Link to Shunt surgery and beta-blockers.

    262. 1993

  262. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, Rodés J. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.  Hepatology  1993;18;5  Link to Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
  263. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Terés J, Bosch J, Bordas JM, Garcia Pagán JC, Feu F, Cirera I, Rodés J. Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial.  Gastroenterology  1993;105;5  Link to Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial.
  264. Journal Article Casadevall M, Panés J, Piqué JM, Marroni N, Bosch J, Whittle BJ. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats.  Hepatology  1993;18;3  Link to Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats.
  265. Journal Article Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.  Hepatology  1993;18;2  Link to Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
  266. Journal Article Salmerón JM, Ruiz del Arbol L, Ginès A, García-Pagán JC, Ginès P, Feu F, Claria J, Rivera F, Bosch J, Arroyo V. Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.  Hepatology  1993;17;5  Link to Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
  267. Journal Article Navasa M, Feu F, García-Pagán JC, Jiménez W, Llach J, Rimola A, Bosch J, Rodés J. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis.  Hepatology  1993;17;3  Link to Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis.
  268. Clinical TrialControlled Clinical TrialJournal ArticleRandomized Controlled Trial Panés J, Bordas JM, Piqué JM, García-Pagán JC, Feu F, Terés J, Bosch J, Rodés J. Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.  Hepatology  1993;17;2  Link to Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.
  269. Journal Article Panés J, Caballería J, Guitart R, Parés A, Soler X, Rodamilans M, Navasa M, Parés X, Bosch J, Rodés J. Determinants of ethanol and acetaldehyde metabolism in chronic alcoholics.  Alcohol. Clin. Exp. Res.  1993;17;1  Link to Determinants of ethanol and acetaldehyde metabolism in chronic alcoholics.
  270. Comparative StudyJournal Article Carreras E, Grañena A, Navasa M, Bruguera M, Marco V, Sierra J, Tassies MD, García-Pagán JC, Martí JM, Bosch J. Transjugular liver biopsy in BMT.  Bone Marrow Transplant.  1993;11;1  Link to Transjugular liver biopsy in BMT.
  271. Journal Article Luca A, Cirera I, García-Pagán JC, Feu F, Pizcueta P, Bosch J, Rodés J. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis.  Gastroenterology  1993;104;1  Link to Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis.
  272. Journal ArticleReview Bosch J, García-Pagán JC, Feu F, Luca A, Fernández M, Pizcueta P, Rodés J. New approaches in the pharmacologic treatment of portal hypertension.  J. Hepatol.  1993;17 Suppl 2  Link to New approaches in the pharmacologic treatment of portal hypertension.

    273. 1992

  273. Journal Article Panés J, Bordas JM, Piqué JM, Bosch J, García-Pagán JC, Feu F, Casadevall M, Terés J, Rodés J. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.  Gastroenterology  1992;103;6  Link to Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.
  274. Journal Article Pizcueta P, Piqué JM, Fernández M, Bosch J, Rodés J, Whittle BJ, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition.  Gastroenterology  1992;103;6  Link to Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition.
  275. Journal Article Casadevall M, Panés J, Piqué JM, Bosch J, Terés J, Rodés J. Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow.  Am. J. Physiol.  1992;263;5 Pt 1  Link to Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow.
  276. Journal ArticleReview Bosch J, Pizcueta MP, Fernández M, Feu F, Cirera I, Luca A, García-Pagán JC. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.  Baillieres Clin. Gastroenterol.  1992;6;3  Link to Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
  277. Journal Article Panés J, Casadevall M, Piqué JM, Bosch J, Whittle BJ, Terés J. Effects of acute normovolemic anemia on gastric mucosal blood flow in rats: role of nitric oxide.  Gastroenterology  1992;103;2  Link to Effects of acute normovolemic anemia on gastric mucosal blood flow in rats: role of nitric oxide.
  278. Journal Article Navasa M, Garcia-Pagán JC, Bosch J, Riera JR, Bañares R, Mas A, Bruguera M, Rodés J. Portal hypertension in acute liver failure.  Gut  1992;33;7  Link to Portal hypertension in acute liver failure.
  279. Journal Article La Villa G, Salmerón JM, Arroyo V, Bosch J, Ginés P, García-Pagán JC, Ginés A, Asbert M, Jiménez W, Rivera F. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.  Gastroenterology  1992;102;6  Link to Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.
  280. Journal Article García-Pagán JC, Navasa M, Rivera F, Bosch J, Rodés J. Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.  Gastroenterology  1992;102;6  Link to Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.
  281. Consensus Development ConferenceJournal ArticleReview de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, Groszmann R, Bosch J, Sauerbruch T, Soederlund C. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990.  J. Hepatol.  1992;15;1-2  Link to Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990.
  282. Journal ArticleReview Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC. Pathophysiology of portal hypertension.  Gastroenterol. Clin. North Am.  1992;21;1  Link to Pathophysiology of portal hypertension.
  283. Comparative StudyEnglish AbstractJournal Article Navasa M, García-Pagán JC, Bosch J, Rodés J. [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices]  Med Clin (Barc)  1992;98;8  Link to [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices]
  284. Journal Article Albillos A, Bañares R, Barrios C, Clemente G, Rossi I, Escartin P, Bosch J. Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects.  Gastroenterology  1992;102;1  Link to Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects.

    285. 1991

  285. Journal Article Pizcueta MP, García-Pagán JC, Fernández M, Casamitjana R, Bosch J, Rodés J. Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.  Gastroenterology  1991;101;6  Link to Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.
  286. Journal Article Nevens F, Pizcueta MP, Fernández M, Bosch J, Rodés J. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.  Hepatology  1991;14;6  Link to Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
  287. Clinical TrialJournal ArticleRandomized Controlled Trial Ruiz del Arbol L, García-Pagán JC, Feu F, Pizcueta MP, Bosch J, Rodés J. Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.  J. Hepatol.  1991;13;2  Link to Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
  288. Case ReportsJournal Article Calvet X, Bruix J, Bosch J, Rodes J. Portal pressure in patients with exudative ascites in the course of acute hepatitis B.  Liver  1991;11;4  Link to Portal pressure in patients with exudative ascites in the course of acute hepatitis B.
  289. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Pérez-Ayuso RM, Piqué JM, Bosch J, Panés J, González A, Pérez R, Rigau J, Quintero E, Valderrama R, Viver J. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis.  Lancet  1991;337;8755  Link to Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis.
  290. Journal ArticleReview Bosch J. [Pharmacologic treatment of portal hypertension]  An Med Interna  1991;8 Suppl 2  Link to [Pharmacologic treatment of portal hypertension]
  291. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial García-Pagán JC, Feu F, Bosch J, Rodés J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.  Ann. Intern. Med.  1991;114;10  Link to Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
  292. Clinical TrialControlled Clinical TrialJournal ArticleRandomized Controlled Trial Feu F, Bordas JM, Garcia-Pagán JC, Bosch J, Rodés J. Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension.  Hepatology  1991;13;5  Link to Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension.
  293. Clinical TrialJournal ArticleMulticenter StudyRandomized Controlled Trial Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodés J, Wright SC, Matloff DS, Garcia-Tsao G, Fisher RL, Navasa M. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.  Hepatology  1991;13;5  Link to Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group.
  294. Case ReportsCommentLetter Bosch J, Coll M, Puig A, Español T, Ibáñez VM, Infante D, Tormo R. Autoimmune hepatitis with fatal outcome.  J. Pediatr.  1991;118;5  Link to Autoimmune hepatitis with fatal outcome.

    295. 1990

  295. Journal Article Bosch J. Splanchnic vasodilation and renal vasoconstriction: a key to the hepatorenal syndrome?  Hepatology  1990;12;6  Link to Splanchnic vasodilation and renal vasoconstriction: a key to the hepatorenal syndrome?
  296. Clinical TrialJournal ArticleRandomized Controlled TrialResearch Support, U.S. Gov't, P.H.S. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.  Gastroenterology  1990;99;5  Link to Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.
  297. Clinical TrialJournal ArticleRandomized Controlled Trial García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.  J. Hepatol.  1990;11;2  Link to Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
  298. Comparative StudyJournal Article Piqué JM, Pizcueta P, Pérez Ayuso RM, Bosch J. Effects of propranolol on gastric microcirculation and acid secretion in portal hypertensive rats.  Hepatology  1990;12;3 Pt 1  Link to Effects of propranolol on gastric microcirculation and acid secretion in portal hypertensive rats.
  299. Clinical TrialJournal ArticleRandomized Controlled Trial Terés J, Planas R, Panes J, Salmeron JM, Mas A, Bosch J, Llorente C, Viver J, Feu F, Rodés J. Vasopressin/nitroglycerin infusion vs. esophageal tamponade in the treatment of acute variceal bleeding: a randomized controlled trial.  Hepatology  1990;11;6  Link to Vasopressin/nitroglycerin infusion vs. esophageal tamponade in the treatment of acute variceal bleeding: a randomized controlled trial.
  300. Case ReportsJournal Article Bosch J, Aguilar JL. [Febrile syndrome, pancytopenia and respiratory insufficiency in a 35-year-old female patient with a 9-year-course disseminated lupus erythema]  Med Clin (Barc)  1990;94;19  Link to [Febrile syndrome, pancytopenia and respiratory insufficiency in a 35-year-old female patient with a 9-year-course disseminated lupus erythema]
  301. Journal Article Silva G, Navasa M, Bosch J, Chesta J, Pilar Pizcueta M, Casamitjana R, Rivera F, Rodés J. Hemodynamic effects of glucagon in portal hypertension.  Hepatology  1990;11;4  Link to Hemodynamic effects of glucagon in portal hypertension.
  302. Journal ArticleReview Agustí AG, Roca J, Bosch J, Rodriguez-Roisin R. The lung in patients with cirrhosis.  J. Hepatol.  1990;10;2  Link to The lung in patients with cirrhosis.
  303. Journal Article Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.  Hepatology  1990;11;2  Link to Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
  304. Journal Article Pizcueta MP, Casamitjana R, Bosch J, Rodés J. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism.  Am. J. Physiol.  1990;258;2 Pt 1  Link to Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism.
  305. Comparative StudyConsensus Development ConferenceJournal ArticleReview Terés J, Bosch J. [Esophageal tamponade]  Gastroenterol. Clin. Biol.  1990;14;1 ( Pt 2)  Link to [Esophageal tamponade]

    306. 1989

  306. Clinical TrialJournal ArticleRandomized Controlled Trial Bosch J, Groszmann RJ, García-Pagán JC, Terés J, García-Tsao G, Navasa M, Mas A, Rodés J. Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.  Hepatology  1989;10;6  Link to Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.
  307. Journal Article Pizcueta MP, de Lacy AM, Kravetz D, Bosch J, Rodés J. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.  Hepatology  1989;10;6  Link to Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
  308. Journal Article Mastai R, Bosch J, Bruix J, Navasa M, Kravetz D, Rodés J. Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.  Hepatology  1989;10;3  Link to Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.
  309. Journal ArticleReview Bosch J, Navasa M, Garcia-Pagán JC, DeLacy AM, Rodés J. Portal hypertension.  Med. Clin. North Am.  1989;73;4  Link to Portal hypertension.
  310. Journal Article Kravetz D, Bosch J, Arderiu M, Pilar Pizcueta M, Rodés J. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.  Hepatology  1989;9;6  Link to Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.
  311. Letter Ruiz del Arbol L, García-Pagán JC, Feu F, Navasa M, Bosch J. Indocyanine-green: infusion rate and reactions.  Ann. Intern. Med.  1989;110;10  Link to Indocyanine-green: infusion rate and reactions.
  312. Clinical TrialControlled Clinical TrialJournal Article Navasa M, Chesta J, Bosch J, Rodés J. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.  Gastroenterology  1989;96;4  Link to Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
  313. Journal Article Rigau J, Bosch J, Bordas JM, Navasa M, Mastai R, Kravetz D, Bruix J, Feu F, Rodés J. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage.  Gastroenterology  1989;96;3  Link to Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage.
  314. English AbstractJournal Article Orriols R, Román A, Bosch J, Sampol G, Bernadó L, Morell F. [Churg-Strauss syndrome: 8 cases in the last 10 years]  Med Clin (Barc)  1989;92;7  Link to [Churg-Strauss syndrome: 8 cases in the last 10 years]
  315. Journal ArticleReview Bosch J, Pagán JC, Bruix J, Ruiz del Arbol L, Pizcueta MP, Navasa M, Feu F, Bru C, Rodés J. Evaluation of the portal hypertensive patient.  J. Gastroenterol. Hepatol.  1989;4 Suppl 1  Link to Evaluation of the portal hypertensive patient.

    316. 1988

  316. Journal ArticleReview Bosch J, Navasa M, Kravetz D, Pizcueta MP, García-Pagán JC, De Lacy AM, Rodés J. Diagnosis and evaluation of portal hypertension.  Z Gastroenterol  1988;26 Suppl 2  Link to Diagnosis and evaluation of portal hypertension.
  317. Journal Article Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.  Gastroenterology  1988;95;3  Link to Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.
  318. Comparative StudyJournal Article Bosch J, Bordas JM, Mastai R, Kravetz D, Navasa M, Chesta J, Pizcueta MP, García-Pagán JC, Rodés J. Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure.  Hepatology  1988;8;4  Link to Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure.
  319. Journal Article Navasa M, Bosch J, Reichen J, Bru C, Mastai R, Zysset T, Silva G, Chesta J, Rodés J. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.  Hepatology  1988;8;4  Link to Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
  320. Journal Article Silva G, Gomis R, Bosch J, Casamitjana R, Mastai R, Navasa M, Rivera F, Rodés J. Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.  J. Hepatol.  1988;6;3  Link to Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.
  321. Journal Article Karmi SA, DePalma R, Bosch J, Dosa S, Michell A. An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.  Transplant. Proc.  1988;20;3 Suppl 3  Link to An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.
  322. Case ReportsLetter Fernández-Solá J, Poch E, Bosch J. [Hemiballism as the presenting form of a hypertensive crisis]  Med Clin (Barc)  1988;91;1  Link to [Hemiballism as the presenting form of a hypertensive crisis]
  323. Comparative StudyJournal Article Ginès P, Jiménez W, Arroyo V, Navasa M, López C, Titó L, Serra A, Bosch J, Sanz G, Rivera F. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction.  Hepatology  1988;8;3  Link to Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction.
  324. Journal Article Reichen J, Bosch J, Staritz M, Kleber G, Sauerbruch T, Burroughs AK, Fleig W, Westaby D, Henderson JM. [The "Liver" Study Group: portal hypertension]  Z Gastroenterol Verh  1988;23  Link to [The "Liver" Study Group: portal hypertension]
  325. Journal Article Panés J, Terés J, Bosch J, Rodés J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes.  Dig. Dis. Sci.  1988;33;4  Link to Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes.
  326. Journal Article Kravetz D, Bosch J, Arderiu MT, Pizcueta MP, Casamitjana R, Rivera F, Rodés J. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.  Am. J. Physiol.  1988;254;3 Pt 1  Link to Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.

    327. 1987

  327. Journal Article Navasa M, Parés A, Bruguera M, Caballería J, Bosch J, Rodés J. Portal hypertension in primary biliary cirrhosis. Relationship with histological features.  J. Hepatol.  1987;5;3  Link to Portal hypertension in primary biliary cirrhosis. Relationship with histological features.
  328. Journal Article Quintero E, Pique JM, Bombi JA, Bordas JM, Sentis J, Elena M, Bosch J, Rodes J. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I.  Gastroenterology  1987;93;5  Link to Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I.
  329. Journal Article Kravetz D, Arderiu MT, Bosch J, Piera C, Setoain J, Rodés J. Increased plasma volume in two models of portal hypertension in the rat: cirrhosis of the liver and partial portal vein ligation.  Rev. Esp. Fisiol.  1987;43;2  Link to Increased plasma volume in two models of portal hypertension in the rat: cirrhosis of the liver and partial portal vein ligation.
  330. Case ReportsLetter de Salas M, Coll J, Navarro G, Bosch J. [Hyperpotassemia induced by heparin]  Med Clin (Barc)  1987;88;19  Link to [Hyperpotassemia induced by heparin]
  331. Journal Article Mastai R, Bosch J, Navasa M, Kravetz D, Bruix J, Viola C, Rodés J. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.  J. Hepatol.  1987;4;1  Link to Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
  332. Journal Article Kravetz D, Arderiu M, Bosch J, Fuster J, Visa J, Casamitjana R, Rodés J. Hyperglucagonemia and hyperkinetic circulation after portocaval shunt in the rat.  Am. J. Physiol.  1987;252;2 Pt 1  Link to Hyperglucagonemia and hyperkinetic circulation after portocaval shunt in the rat.
  333. Case ReportsJournal Article Bernadó L, Admella C, Lucaya J, Sanchez de Toledo J, Bosch J. Infantile fibrosarcoma of femur.  Pediatr Pathol  1987;7;2  Link to Infantile fibrosarcoma of femur.

    334. 1986

  334. Clinical TrialControlled Clinical TrialJournal ArticleRandomized Controlled Trial Mastai R, Grande L, Bosch J, Bruix J, Rigau J, Kravetz D, Navasa M, Pera C, Rodés J. Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension.  Hepatology  1986;6;6  Link to Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension.
  335. Journal ArticleReview Bosch J, Mastai R, Kravetz D, Navasa M, Rodés J. Hemodynamic evaluation of the patient with portal hypertension.  Semin. Liver Dis.  1986;6;4  Link to Hemodynamic evaluation of the patient with portal hypertension.
  336. Journal Article Ariza J, Gudiol F, Dolz C, Xiol J, Liñares J, Bosch J, Pallares R. Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis.  Hepatology  1986;6;5  Link to Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis.
  337. Comparative StudyJournal Article Bosch J, Bordas JM, Rigau J, Viola C, Mastai R, Kravetz D, Navasa M, Rodés J. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy.  Hepatology  1986;6;4  Link to Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy.

    338. 1985

  338. English AbstractJournal Article Rigau J, Bordas JM, Bosch J, Rodés J. [Development and validation of a non-invasive method for the endoscopic measurement of the pressure of esophageal varices]  Med Clin (Barc)  1985;84;13  Link to [Development and validation of a non-invasive method for the endoscopic measurement of the pressure of esophageal varices]
  339. Journal Article Bruix J, Bosch J, Kravetz D, Mastai R, Rodés J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver.  Gastroenterology  1985;88;2  Link to Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver.
  340. Journal Article Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodés J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients.  J. Hepatol.  1985;1;2  Link to Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients.
  341. Journal Article Bosch J. Effect of pharmacological agents on portal hypertension: a haemodynamic appraisal.  Clin Gastroenterol  1985;14;1  Link to Effect of pharmacological agents on portal hypertension: a haemodynamic appraisal.

    342. 1984

  342. Journal Article Bosch J, Masti R, Kravetz D, Bruix J, Gaya J, Rigau J, Rodes J. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.  Hepatology  1984;4;6  Link to Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.
  343. Case ReportsLetter Monsó E, Fité E, Bosch J, Vidal Pla R. [2 cases of scrofula following the ingestion of milk]  Med Clin (Barc)  1984;83;7  Link to [2 cases of scrofula following the ingestion of milk]
  344. Journal Article Bosch J, Gomis R, Kravetz D, Casamitjana R, Terés J, Rivera F, Rodés J. Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis.  Am. J. Physiol.  1984;247;3 Pt 1  Link to Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis.
  345. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Kravetz D, Bosch J, Terés J, Bruix J, Rimola A, Rodés J. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage.  Hepatology  1984;4;3  Link to Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage.
  346. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Bosch J, Groszmann RJ. Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis.  Hepatology  1984;4;3  Link to Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis.
  347. Editorial Bosch J. [Why do esophageal varices bleed?]  Med Clin (Barc)  1984;82;9  Link to [Why do esophageal varices bleed?]
  348. Journal Article Kravetz D, Bruix J, Bosch J. [Pharmacological treatment of digestive hemorrhage due to the rupture of esophageal varices]  Acta Gastroenterol. Latinoam.  1984;14;2  Link to [Pharmacological treatment of digestive hemorrhage due to the rupture of esophageal varices]

    349. 1983

  349. Case ReportsJournal Article Viola C, Viñeta L, Bosch J, Rodés J. Exudative ascites in the course of acute type B hepatitis.  Hepatology  1983;3;6  Link to Exudative ascites in the course of acute type B hepatitis.
  350. Journal Article Bosch J, Enriquez R, Groszmann RJ, Storer EH. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.  Hepatology  1983;3;6  Link to Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.
  351. Journal Article Pena JM, Aulesa C, Viñas O, Bosch J, Farriol M, Schwartz S. Intralipid and free plasmatic tryptophan in vitro.  Rev. Esp. Fisiol.  1983;39;1  Link to Intralipid and free plasmatic tryptophan in vitro.
  352. Journal Article Webb S, Kravetz D, Bosch J, Wass JA, Evans J, Gomis R, Rees LH, Rodés J. Splanchnic and hepatic metabolism of somatostatin: a study in cirrhotic patients with a portacaval shunt.  Hepatology  1983;3;2  Link to Splanchnic and hepatic metabolism of somatostatin: a study in cirrhotic patients with a portacaval shunt.

    353. 1982

  353. Case ReportsEnglish AbstractJournal Article Ribera JM, Urbano-Márquez A, Arroyo V, Bosch J, Estruch R, Grau JM. [Portal hypertension, ascites and functional renal insufficiency in a patient with agnogenic myeloid metaplasia]  Med Clin (Barc)  1982;79;10  Link to [Portal hypertension, ascites and functional renal insufficiency in a patient with agnogenic myeloid metaplasia]
  354. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Groszmann RJ, Kravetz D, Bosch J, Glickman M, Bruix J, Bredfeldt J, Conn HO, Rodes J, Storer EH. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.  Hepatology  1982;2;6  Link to Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.

    355. 1981

  355. Case ReportsLetter Ballas SK, Bosch J, Miguel O. Passive transfer of anti-E antibody.  Transfusion  1981;21;5  Link to Passive transfer of anti-E antibody.
  356. Journal Article Mas A, Bosch J, Piera C, Arroyo V, Setoain J, Rodes J. Intracellular and exchangeable potassium in cirrhosis. Evidence against the occurrence of potassium depletion in cirrhosis with ascites.  Dig. Dis. Sci.  1981;26;8  Link to Intracellular and exchangeable potassium in cirrhosis. Evidence against the occurrence of potassium depletion in cirrhosis with ascites.
  357. Journal Article Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-López F, Rodés J. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.  Eur. J. Clin. Invest.  1981;11;3  Link to Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
  358. Comparative StudyJournal Article Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.  Gastroenterology  1981;80;3  Link to Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
  359. Journal Article Arroyo V, Bosch J, Gaya-Beltrán J, Kravetz D, Estrada L, Rivera F, Rodés J. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.  Ann. Intern. Med.  1981;94;2  Link to Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.

    360. 1980

  360. Journal Article Arroyo V, Bosch J, Casamitjana R, Cabrera J, Rivera F, Rodés J. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.  Gut  1980;21;10  Link to Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
  361. Journal ArticleResearch Support, U.S. Gov't, P.H.S. Kahn T, Bosch J, Wiener P, Dikman S. Course of gentamicin nephrotoxicity.  Toxicology  1980;16;1  Link to Course of gentamicin nephrotoxicity.
  362. Journal Article Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, Navarro-Lopez F, Rodes J. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.  Gastroenterology  1980;78;1  Link to Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.

    363. 1979

  363. Case ReportsEnglish AbstractJournal Article Xaubet A, Aranguibel F, Cecilia A, Arroyo V, Bosch J, Rodés J, Gibert-Queraltó J. [Treatment of the syndrome of inappropriate antidiuretic hormone secretion with demethylchlortetracycline (author's transl)]  Med Clin (Barc)  1979;72;8  Link to [Treatment of the syndrome of inappropriate antidiuretic hormone secretion with demethylchlortetracycline (author's transl)]
  364. Journal Article Arroyo V, Bosch J, Mauri M, Viver J, Mas A, Rivera F, Rodes J. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.  Eur. J. Clin. Invest.  1979;9;1  Link to Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.
Back to page of Bosch, Jaime.

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.